Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Videoconference-Based Brief Cognitive-Behavioral Therapy (V-BCBT) for Patients With Mood Disorders at High Risk for Suicide: Identifying Inflammatory Biomarkers of Suicide Risk and Examining Their Mediating Role in Treatment Effects

NCT07857291 is registered in ClinicalTrials.gov with Hyung Keun Park as lead sponsor.

NCT NCT07857291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Videoconference-Based Brief Cognitive-Behavioral Therapy (V-BCBT) for Patients With Mood Disorders at High Risk for Suicide: Identifying Inflammatory Biomarkers of Suicide Risk and Examining Their Mediating Role in Treatment Effects
Lead sponsor
Hyung Keun Park
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
August 31, 2031
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive behavior therapy, mood disorders, suicidal ideation and behavior, suicide attempt